Author

Beau M. Idler

Mayo ClinicORCID 0000-0003-4895-2185Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:Ribo-seq· 1 Approach:statistical model· 1

Frequent Co-Authors

Amber BaldwiniD· 1 shared Brett M. StevensiD· 1 shared Daniel W. SherbenouiD· 1 shared Denis J. OhlstromiD· 1 shared Kady A. DennisiD· 1 shared Kate MatliniD· 1 shared Katherine F. VaethiD· 1 shared Lauren T. ReimaniD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Amber BaldwinORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyMolecular Cancer ResearchPeer-reviewedMar 6, 2025

Ribosome Profiling Reveals Translational Reprogramming via mTOR Activation in Omacetaxine Resistant Multiple Myeloma

Zachary J. Walker, Katherine F. Vaeth, Amber Baldwin…·Daniel W. Sherbenou

This study identifies translational reprogramming via mTOR activation as a mechanism of omacetaxine resistance in multiple myeloma and suggests combination therapy with mTOR inhibitors.

3 citations

humanbulk RNA-seq

𝕏 PostBluesky